The Minneapolis plant of Syntegon is proud to announce the delivery of its 16th and 17th model FLT small batch vial filler for ATMP applications. Configured to fill gene therapy products in an isolator and oncolytic immunotherapies and vaccines in a RABS, respectively, these latest deliveries of the proven FLT platform for RTU vials exemplify the trend towards smaller batches of higher value products and highlight Syntegon’s track record of providing solutions that meet the exacting requirements of the rapidly growing ATMP segment.
The Syntegon FLT vial filler is designed as a platform for clinical trial production and small batch manufacturing. Combining Syntegon’s know-how and design experience in vial filler and isolator technologies, the FLT features industrial grade robustness with an easy setup and short change-over times. The FLT is a full-featured filling system with much of the functionality of full-scale production systems. The full range of features available on the FLT not only ensures dependable automated production, it also limits product loss and increases adaptability to run a wide range of products.
Interested in learning more? Please contact us. Our subject matter experts are available to engage on your specific application.
FLT # 17 configured to fill oncolytic immunotherapies and vaccines in a RABS
